TWD 20.9
(-0.71%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 216.37 Million TWD | 5.64% |
2022 | 204.82 Million TWD | 15.73% |
2021 | 176.97 Million TWD | -6.62% |
2020 | 189.53 Million TWD | 1.27% |
2019 | 187.14 Million TWD | 16.69% |
2018 | 160.38 Million TWD | 1.85% |
2017 | 157.47 Million TWD | 53.53% |
2016 | 102.56 Million TWD | -37.32% |
2015 | 163.64 Million TWD | 27.87% |
2014 | 127.97 Million TWD | -14.59% |
2013 | 149.83 Million TWD | 79.53% |
2012 | 83.45 Million TWD | 39.28% |
2011 | 59.92 Million TWD | 22.71% |
2010 | 48.83 Million TWD | 39.9% |
2009 | 34.9 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 30.62 Million TWD | -25.38% |
2024 Q2 | 65.52 Million TWD | 225.56% |
2023 Q4 | 41.04 Million TWD | 8.1% |
2023 FY | 216.37 Million TWD | 5.64% |
2023 Q1 | 49.94 Million TWD | 8.86% |
2023 Q3 | 37.97 Million TWD | -32.68% |
2023 Q2 | 56.4 Million TWD | 12.93% |
2022 Q3 | 49.54 Million TWD | -11.08% |
2022 Q1 | 53.68 Million TWD | 8.47% |
2022 FY | 204.82 Million TWD | 15.73% |
2022 Q4 | 45.87 Million TWD | -7.4% |
2022 Q2 | 55.71 Million TWD | 3.79% |
2021 Q1 | 41.24 Million TWD | -12.62% |
2021 FY | 176.97 Million TWD | -6.62% |
2021 Q4 | 49.49 Million TWD | 27.55% |
2021 Q3 | 38.8 Million TWD | -14.53% |
2021 Q2 | 45.39 Million TWD | 10.08% |
2020 Q4 | 47.19 Million TWD | 1.28% |
2020 Q2 | 44.89 Million TWD | -11.69% |
2020 FY | 189.53 Million TWD | 1.27% |
2020 Q1 | 50.83 Million TWD | 12.4% |
2020 Q3 | 46.6 Million TWD | 3.8% |
2019 Q1 | 49.56 Million TWD | -4.62% |
2019 Q3 | 44.83 Million TWD | -5.63% |
2019 Q2 | 47.51 Million TWD | -4.13% |
2019 Q4 | 45.23 Million TWD | 0.87% |
2019 FY | 187.14 Million TWD | 16.69% |
2018 Q2 | 30.09 Million TWD | -7.81% |
2018 Q3 | 45.68 Million TWD | 51.8% |
2018 Q4 | 51.96 Million TWD | 13.76% |
2018 FY | 160.38 Million TWD | 1.85% |
2018 Q1 | 32.64 Million TWD | -31.47% |
2017 Q3 | 44.99 Million TWD | 35.45% |
2017 Q4 | 47.63 Million TWD | 5.88% |
2017 FY | 157.47 Million TWD | 53.53% |
2017 Q1 | 31.63 Million TWD | 69.97% |
2017 Q2 | 33.21 Million TWD | 4.99% |
2016 FY | 102.56 Million TWD | -37.32% |
2016 Q3 | 29.39 Million TWD | 3.25% |
2016 Q4 | 18.61 Million TWD | -36.68% |
2016 Q2 | 28.47 Million TWD | 9.12% |
2016 Q1 | 26.09 Million TWD | -17.36% |
2015 FY | 163.64 Million TWD | 27.87% |
2015 Q4 | 31.57 Million TWD | 0.0% |
2015 Q3 | 31.57 Million TWD | -0.77% |
2015 Q2 | 31.81 Million TWD | 0.0% |
2015 Q1 | 31.81 Million TWD | 115.6% |
2014 Q1 | 24.51 Million TWD | -37.14% |
2014 Q2 | 24.51 Million TWD | 0.0% |
2014 Q4 | 14.75 Million TWD | 0.0% |
2014 Q3 | 14.75 Million TWD | -39.8% |
2014 FY | 127.97 Million TWD | -14.59% |
2013 Q2 | 25.99 Million TWD | 0.0% |
2013 Q1 | 25.99 Million TWD | 14.56% |
2013 Q3 | 39 Million TWD | 50.04% |
2013 Q4 | 39 Million TWD | 0.0% |
2013 FY | 149.83 Million TWD | 79.53% |
2012 FY | 83.45 Million TWD | 39.28% |
2012 Q3 | 22.68 Million TWD | 0.0% |
2012 Q4 | 22.68 Million TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2011 FY | 59.92 Million TWD | 22.71% |
2011 Q2 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2010 FY | 48.83 Million TWD | 39.9% |
2010 Q4 | - TWD | 0.0% |
2009 FY | 34.9 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 919.21 Million TWD | 76.461% |
Apex Medical Corp. | 944.09 Million TWD | 77.082% |
Applied BioCode Corporation | 455.44 Million TWD | 52.492% |